Xinhua World News Summary at 0030 GMT, March 28
Xinhua, March 28, 2017 Adjust font size:
A military spokesman said that IS affiliates are still active in southern Sirte despite the defeat by the government's forces.
Mohamed Gunono, spokesman of the air emergency chamber of the UN-backed government, said that the current political division is helping IS fighters regroup. (Libya-IS)
- - - -
TEHRAN -- Iranian Foreign Ministry called for an immediate halt to bloodshed in Yemen and urged efforts to start a political process for formation of a national unity government in the Arab country, Tasnim news agency reported on Monday.
The Iranian Foreign Ministry condemned what it called the "blatant aggression" on Yemen that has brought about deaths, famine and starvation on the Yemeni people. (Iran-Yemen-conflicts)
- - - -
WASHINGTON -- U.S. President Donald Trump will sign an executive order on Tuesday aimed at reversing his predecessor's efforts to address climate change, White House spokesman Sean Spicer said on Monday.
"Tomorrow, the president will sign an executive order to strengthen the nation's energy security by reducing unnecessary regulatory obstacles that restrict the responsible use of domestic energy resources," Spicer said at his White House press briefing. (U.S.-Climate-Trump)
- - - -
BERLIN -- Turks living in Germany on Monday began voting in a referendum that proposes amending Turkish constitution.
The referendum, if approved, will change Turkey's parliamentarism into a presidential regime, which will grant Turkish President Recep Tayyip Erdogan more decisive power. (Germany-voting-Turkey)
- - - -
LONDON -- The London stock market listed company AstraZeneca Monday announced that the China Food and Drug Administration (CFDA) has granted marketing authorization for its lung cancer pill Tagrisso in China.
Tagrisso (osimertinib) is designed for the treatment of adult patients with certain genetic mutations, which is the first AstraZeneca medicine approved under the CFDA's Priority Review pathway, using an accelerated timeline for an innovative medicine. (Britain-china-medicine) Endi